التفاصيل البيبلوغرافية
| العنوان: |
Clinical Significance of Intraductal Carcinoma of the Prostate After High-Dose Brachytherapy With External Beam Radiation Therapy: A Single Institution Series and an Updated Meta-Analysis. |
| المؤلفون: |
Keiichiro Miyajima, Shun Sato, Naoki Uchida, Hirotaka Suzuki, Kosuke Iwatani, Yu Imai, Koichi Aikawa, Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Mariko Honda, Yusuke Koike, Jun Miki, Kenta Miki, Tatsuya Shimomura, Steffi Yuen, Yuta Yamada, Manabu Aoki, Hiroyuki Takahashi |
| المصدر: |
Clinical Genitourinary Cancer; Apr2024, Vol. 22 Issue 2, p149-156.e1, 9p |
| مصطلحات موضوعية: |
PROSTATE cancer, CANCER radiotherapy, DISEASE incidence, DISEASE progression, CANCER relapse |
| مستخلص: |
Intraductal carcinoma of the prostate (IDC-P) has been recognized as an adverse pathological feature of prostate cancer (PCa). We performed a retrospective analysis of 138 patients with clinically high-risk, very high-risk, or locally advanced PCa who received high-dose-rate brachytherapy with external beam radiation therapy, elucidating a significant association between the presence of IDC-P and a higher incidence of disease progression. Background: We compared oncological outcomes between prostate cancer (PCa) patients with and without intraductal carcinoma of the prostate (IDC-P) after high-dose-rate brachytherapy (HDR-BT) with external beam radiation therapy (EBRT). Methods: We performed a retrospective analysis of 138 patients with clinically high-risk, very highrisk, or locally advanced PCa who received HDR-BT with EBRT. Of these, 70 (50.7 %) patients were diagnosed with IDC-P; 68 (49.3 %) patients with acinar adenocarcinoma of prostate. The oncological outcomes, including biochemical recurrence-free survival (BCRFS) and clinical progression-free survival (CPFS), were assessed using Kaplan-Meier curves. Additionally, Cox proportional hazards models were used to identify significant prognostic indicators or biochemical recurrence (BCR). Meta-analysis of existing literatures was performed to evaluate the risk of BCR in patients with IDC-P after radiation therapy, compared to those without IDC-P. Results: Kaplan-Meier curves demonstrated significantly inferior BCRFS and CPFS in patients with IDC-P. Multivariate analysis revealed that IDC-P and Grade Group 5 status were associated with increased BCR risk. in our meta-analysis, IDC-P was associated with BCR (HR = 2.13, P = .003). Conclusion: Amongst the patients who received HDR-BT, patients with IDC-P displayed significantly more rapid disease progression, compared with patients who did not have IDC-P. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Genitourinary Cancer is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text via ClinicalKey 
Full Text Finder